Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

  • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 2301 to 2350 of 3228 in total
    Value Type: Ranked
    Network Comparison Type: Divided
    Interaction Map: High confidence
    Filtered: 1
    \def\wcA{0.14285714285714\textwidth} \def\wcB{0.14285714285714\textwidth} \def\wcC{0.14285714285714\textwidth} \def\wcD{0.14285714285714\textwidth} \def\wcE{0.14285714285714\textwidth} \def\wcF{0.14285714285714\textwidth} \begin{longtable}{|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 2301\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent NMNAT3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent nicotinamide nucleotide adenylyltransferase 3; pyridine nucleotide adenylyltransferase 3. [source:refseq;acc:nm\_178177]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.392\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 218.498\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.00509\vspace{3pt}}}\\\cline{1-5} \parbox{\wcA}{\vspace{3pt}\noindent 2302\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent HMGCS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent hydroxymethylglutaryl-coa synthase, mitochondrial precursor (ec 2.3.3.10) (hmg-coa synthase) (3-hydroxy-3-methylglutaryl coenzyme a synthase). [source:swissprot;acc:p54868]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 191.567\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 192.542\vspace{3pt}}}&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2303\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent HMGCR\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3-hydroxy-3-methylglutaryl-coenzyme a reductase (ec 1.1.1.34) (hmg-coa reductase). [source:swissprot;acc:p04035]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2304\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent HMGCS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent hydroxymethylglutaryl-coa synthase, cytoplasmic (ec 2.3.3.10) (hmg-coa synthase) (3-hydroxy-3-methylglutaryl coenzyme a synthase). [source:swissprot;acc:q01581]\vspace{3pt}}&&&\\\cline{1-5} \parbox{\wcA}{\vspace{3pt}\noindent 2305\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ALDH18A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent delta 1-pyrroline-5-carboxylate synthetase (p5cs) [includes: glutamate 5-kinase (ec 2.7.2.11) (gamma-glutamyl kinase) (gk); gamma-glutamyl phosphate reductase (gpr) (ec 1.2.1.41) (glutamate-5-semialdehyde dehydrogenase) (glutamyl-gamma-semialdehyde dehydrogenase)]. [source:swissprot;acc:p54886]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.392\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 218.498\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2306\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ACAT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent acetyl-coa acetyltransferase, mitochondrial precursor (ec 2.3.1.9) (acetoacetyl-coa thiolase) (t2). [source:swissprot;acc:p24752]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 191.571\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 192.544\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.00508\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2307\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PRKAR2A\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent camp-dependent protein kinase type ii-alpha regulatory chain. [source:swissprot;acc:p13861]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 215.554\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 214.467\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.00507\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2308\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PRKX\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent protein kinase pkx1 (ec 2.7.1.-). [source:swissprot;acc:p51817]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 215.543\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 214.459\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.00505\vspace{3pt}}}\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 2309\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PRKACG\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent camp-dependent protein kinase, gamma-catalytic subunit (ec 2.7.1.37) (pka c-gamma). [source:swissprot;acc:p22612]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 215.542\vspace{3pt}}&&\\\cline{1-5} \parbox{\wcA}{\vspace{3pt}\noindent 2310\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent UBC\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent ubiquitin. [source:swissprot;acc:p02248]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 216.617\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 215.529\vspace{3pt}}&\\\cline{1-5} \parbox{\wcA}{\vspace{3pt}\noindent 2311\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PRKACB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent camp-dependent protein kinase, beta-catalytic subunit (ec 2.7.1.37) (pka c-beta). [source:swissprot;acc:p22694]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 215.542\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 214.459\vspace{3pt}}}&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2312\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PRKACA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent camp-dependent protein kinase, alpha-catalytic subunit (ec 2.7.1.37) (pka c-alpha). [source:swissprot;acc:p17612]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2313\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PRKAR2B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent camp-dependent protein kinase type ii-beta regulatory chain. [source:swissprot;acc:p31323]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 215.529\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 214.449\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.00504\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2314\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent UBE2D2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent ubiquitin-conjugating enzyme e2-17 kda 2 (ec 6.3.2.19) (ubiquitin- protein ligase) (ubiquitin carrier protein) (e2(17)kb 2). [source:swissprot;acc:p51669]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 194.743\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 195.708\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.00496\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2315\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ACACB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent acetyl-coa carboxylase 2 (ec 6.4.1.2) (acc-beta) [includes: biotin carboxylase (ec 6.3.4.14)]. [source:swissprot;acc:o00763]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 194.825\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 195.787\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.00494\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2316\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 12 (26s proteasome regulatory subunit p55). [source:swissprot;acc:o00232]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.241\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 218.311\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.00493\vspace{3pt}}}\\\cline{1-5} \parbox{\wcA}{\vspace{3pt}\noindent 2317\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PPP6C\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent serine/threonine protein phosphatase 6 (ec 3.1.3.16) (pp6). [source:swissprot;acc:o00743]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 194.834\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 195.794\vspace{3pt}}}&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2318\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent SAPS3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent sporulation-induced transcript 4-associated protein. [source:refseq;acc:nm\_018312]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2319\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ACACA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent acetyl-coa carboxylase 1 (ec 6.4.1.2) (acc-alpha) [includes: biotin carboxylase (ec 6.3.4.14)]. [source:swissprot;acc:q13085]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 194.842\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 195.8\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.00492\vspace{3pt}}}\\\cline{1-5} \parbox{\wcA}{\vspace{3pt}\noindent 2320\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent RAD54L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent rad54-like protein; rad54 homolog. [source:refseq;acc:nm\_003579]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 219.292\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 218.218\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2321\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent tetratricopeptide repeat protein 4 (my044 protein). [source:swissprot;acc:o95801]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 203.909\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 202.925\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.00485\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2322\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PDSS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent trans-prenyltransferase; polyprenyl pyrophosphate synthetase. [source:refseq;acc:nm\_014317]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 236.023\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 234.905\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.00476\vspace{3pt}}}\\\cline{1-5} \parbox{\wcA}{\vspace{3pt}\noindent 2323\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent NARS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent asparaginyl-trna synthetase, cytoplasmic (ec 6.1.1.22) (asparagine-- trna ligase) (asnrs). [source:swissprot;acc:o43776]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 192.773\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 193.691\vspace{3pt}}&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2324\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PSMB1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent proteasome subunit beta type 1 (ec 3.4.25.1) (proteasome component c5) (macropain subunit c5) (multicatalytic endopeptidase complex subunit c5) (proteasome gamma chain). [source:swissprot;acc:p20618]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.129\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.129\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.00474\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2325\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent MTFMT\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent methionyl-trna formyltransferase, mitochondrial precursor (ec 2.1.2.9) (mtfmt). [source:swissprot;acc:q96dp5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 221.728\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 220.685\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.00473\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2326\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent MAP2K4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent dual specificity mitogen-activated protein kinase kinase 4 (ec 2.7.1.-) (map kinase kinase 4) (jnk activating kinase 1) (c-jun n- terminal kinase kinase 1) (jnkk) (sapk/erk kinase 1) (sek1). [source:swissprot;acc:p45985]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 220.076\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 219.05\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.00468\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2327\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PSMC4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 26s protease regulatory subunit 6b (mip224) (mb67 interacting protein) (tat-binding protein-7) (tbp-7). [source:swissprot;acc:p43686]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.413\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 218.426\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.00466\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2328\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent REXO4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent xpmc2 prevents mitotic catastrophe 2 homolog; xenopus prevents mitotic catastrophe 2 homolog. [source:refseq;acc:nm\_020385]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 209.326\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 208.357\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.00465\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2329\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent PSMD13\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 26s proteasome non-atpase regulatory subunit 13 (26s proteasome regulatory subunit s11) (26s proteasome regulatory subunit p40.5). [source:swissprot;acc:q9unm6]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.112\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 218.116\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.00462\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2330\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent FARSB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent phenylalanyl-trna synthetase beta chain (ec 6.1.1.20) (phenylalanine-- trna ligase beta chain) (phers) (hspc173). [source:swissprot;acc:q9nsd9]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 214.213\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.235\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.00459\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2331\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent MIZF\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent mbd2 (methyl-cpg-binding protein)-interacting zinc finger protein. [source:refseq;acc:nm\_015517]\vspace{3pt}}&\multirow{12}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 229.258\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 230.294\vspace{3pt}}}&\multirow{12}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.00452\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2332\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent TMOD4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent skeletal muscle tropomodulin (sk-tmod) (tropomodulin 4). [source:swissprot;acc:q9nzq9]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2333\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent TMOD3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent ubiquitous tropomodulin (u-tmod) (tropomodulin 3). [source:swissprot;acc:q9nyl9]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2334\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent TMOD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent tropomodulin 1 (erythrocyte tropomodulin) (e-tmod). [source:swissprot;acc:p28289]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2335\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent SNX9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent sorting nexin 9 (sh3 and px domain-containing protein 1) (sdp1 protein). [source:swissprot;acc:q9y5x1]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2336\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent TMOD2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent neuronal tropomodulin (n-tmod) (tropomodulin 2). [source:swissprot;acc:q9nzr1]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2337\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DLX2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent homeobox protein dlx-2. [source:swissprot;acc:q07687]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2338\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DLX5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent homeobox protein dlx-5. [source:swissprot;acc:p56178]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2339\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent MPPED2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent fetal brain protein 239 (239fb). [source:swissprot;acc:q15777]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2340\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DLX3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent homeobox protein dlx-3. [source:swissprot;acc:o60479]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2341\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent TNK2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent activated p21cdc42hs kinase. [source:refseq;acc:nm\_005781]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2342\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent MAP3K7IP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent mitogen-activated protein kinase kinase kinase 7 interacting protein 2 isoform 1; tak1-binding protein 2. [source:refseq;acc:nm\_015093]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2343\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent glycine cleavage system h protein, mitochondrial precursor. [source:swissprot;acc:p23434]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.222\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.00451\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2344\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent DAGLB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent kccr13l. [source:refseq;acc:nm\_139179]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 219.878\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 218.893\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.0045\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2345\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent RAD51\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent dna repair protein rad51 homolog 1 (hrad51) (hsrad51). [source:swissprot;acc:q06609]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2346\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent NEK1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent serine/threonine-protein kinase nek1 (ec 2.7.1.37) (nima-related protein kinase 1) (ny-ren-55 antigen). [source:swissprot;acc:q96py6]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 217.057\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 218.03\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.00448\vspace{3pt}}}\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2347\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent NEK3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent serine/threonine-protein kinase nek3 (ec 2.7.1.37) (nima-related protein kinase 3) (hspk 36). [source:swissprot;acc:p51956]\vspace{3pt}}&&&\\\cline{1-3} \parbox{\wcA}{\vspace{3pt}\noindent 2348\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent GAPDH\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent glyceraldehyde 3-phosphate dehydrogenase, liver (ec 1.2.1.12) (gapdh). [source:swissprot;acc:p04406]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2349\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent FBLN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent fibulin-1 precursor. [source:swissprot;acc:p23142]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 192.348\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 191.503\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.00441\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 2350\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent CNDP2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent cytosolic nonspecific dipeptidase (glutamate carboxypeptidase-like protein 1). [source:swissprot;acc:q96kp4]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 209.811\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 210.733\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.00439\vspace{3pt}}\\\hline nd{longtable}
    Legend:
    - Rank is the rank after comparing the two networks
    - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    - Hugo is the HGNC identifier if it exists
    - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    - Filtered specifies whether we only included the high confidence microarry measurements or not.

    - http://analysis.yellowcouch.org/